Navigation Links
Biological Product Shows Promise Against Gum Disease
Date:4/4/2009

When tested in rabbits, resolvins reduced inflammation ,,,,

SATURDAY, April 4 (HealthDay News) -- Resolvins, a new family of biologically active products of omega-3 fatty acids, may be able to remedy the inflammation of periodontal disease and restore gums to health, say Boston University researchers.

Two types of resolvins are made from the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), both of which keep blood triglycerides under control and may inhibit the progression of atherosclerosis. EPA and DHA help reduce inflammation and are often used to help people with inflammatory conditions such as rheumatoid arthritis and Crohn's disease, according to background information in a new release from the International & American Association for Dental Research.

Resolvins of the E series (RvE1) are derived from EPA, and resolvins of the D series (RvD1) are derived from DHA. Previous research showed that RvE1 provided protection against soft tissue and bone loss associated with gum disease and actually restored lost soft tissue and bone to healthy levels.

In this new study, the researchers caused gum disease in rabbits by applying P. gingivalis, the bacteria that causes gum disease in humans. Treatment with RvD1 was beneficial.

The study was to be presented Saturday at the research association's meeting in Miami.

The finding supports the researchers' hypothesis that DHA-derived resolvins, as well as those derived from EPA, have the potential to resolve inflammation and restore periodontal health, the association said in its news release.

More information

The American Academy of Periodontology has more about gum disease.



-- Robert Preidt



SOURCE: International & American Association for Dental Research, news release, April 4, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Thomson Scientific Announces BONDplus for Biological Researchers
2. Neurobiological Technologies Reports Going Concern Qualification
3. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
4. Study questions assumptions about human sensitivity to biological motion
5. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
6. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
7. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
8. Biological markers of prostate cancer shed light on cancer burden faced by African-American men
9. Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies
10. Biological Link Between BRCA1 and Breast Cancer Detailed
11. Boston IVF is First in Northeast to Offer Pioneering Test of Womens Biological Clock
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biological Product Shows Promise Against Gum Disease
(Date:2/5/2016)... , ... February 05, 2016 , ... ... the addition of micro-needling services in their Napa Valley office. The technique utilizes ... Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of only a ...
(Date:2/5/2016)... ... , ... US Sports Camps , official operators of Nike Yoga Camps, ... yoga training. ChildLight Yoga Studio is centrally situated in the picturesque New England city ... Studio founder Lisa Flynn expresses her excitement, “We are thrilled to be partnering with ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Boar’s Head ... just in time for this weekend’s Big Game. Take the stress out of your ... will keep your guests happy at every stage of the game. , “The key ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Ben ... that it is now welcoming orthodontist, Dr. Amanda Cheng, to the practice. With ... of oral health care, including general dentistry, cosmetic treatments, periodontics, implant dentistry ...
(Date:2/5/2016)... ... February 05, 2016 , ... On ... Rare Diseases, a continuing medical education (CME) event presented by the Association for ... kind—and a first for ACCORD, whose mission is to provide education, tools, and ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... -- Mettler-Toledo International Inc. (NYSE: MTD ) today ... the highlights: , Sales in local currency ... year.  Reported sales decreased 3% as currency reduced sales ... earnings per diluted share as reported (EPS) were $4.44, ... EPS was $4.65, an increase of 10% over the ...
(Date:2/4/2016)... 4, 2016  AMRI (NASDAQ:  AMRI) today announced that ... and President of Pfizer Global Supply, has been elected to ... 2016. In addition, the Company announced that Mr. Gabe ... since 2010, has retired from the AMRI Board of Directors ... other business ventures.  William S. Marth , ...
Breaking Medicine Technology: